NVTA - Invitae Corp - SEC Form 4 Insider Trading Screener

Services - Health Services - Medical Laboratories - NVTA (1501134)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
21 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S6-3+1+3+0

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2018-11-27
NVTAAguiar EricDirS - Sale$13.50-10,0000-100%-$135,000
2018-11-16
NVTADumond PattySee RemarksS - Sale$12.90-2,00096,811-2%-$25,800
M
2018-09-18
NVTADumond PattySee RemarksS - Sale$16.58-64598,811-1%-$10,695
2018-09-09
NVTAStueland KatherineChief Commercial OfficerS - Sale$13.62-595191,9630%-$8,104
2018-05-15
NVTAGuyer Shelly DCFOS - Sale$6.96-5,13539,865-11%-$35,740
2018-05-15
NVTAGeorge Sean EPres, CEOS - Sale$6.96-20,311409,289-5%-$141,365
2018-05-15
NVTANussbaum Robert LChief Medical OfficerS - Sale$6.96-6,70254,435-11%-$46,646
2018-05-15
NVTABendekgey E LeeCOOS - Sale$6.96-6,38852,396-11%-$44,460
2018-05-15
NVTABrida ThomasGCS - Sale$6.96-1,97925,973-7%-$13,774
2018-05-15
NVTAStueland KatherineChief Commercial OfficerS - Sale$6.96-6,01252,558-10%-$41,844
2018-05-15
NVTADumond PattySee RemarksS - Sale$6.96-5,01454,456-8%-$34,897
2018-04-02
NVTAScott Randal WExec COBP - Purchase$4.50+44,4443,550,669+1%+$199,998
2018-03-28
NVTABaker Bros. Advisors LP10%P - Purchase$4.50+1,111,1117,553,553+17%+$5,000,000
M
2017-10-09
NVTADumond PattyVP Fin., Principal Acct. OfficS - Sale$10.00-2,49752,168-5%-$24,970
2017-09-12
NVTAStueland KatherineChief Commercial OfficerS - Sale$9.40-61258,570-1%-$5,753
2017-02-16
NVTABrida ThomasGCS - Sale$9.69-76624,720-3%-$7,420+7+6+6
2017-02-15
NVTAStueland KatherineChief Commercial OfficerS - Sale$9.50-91159,182-2%-$8,655-50+2
2017-02-15
NVTANussbaum Robert LChief Medical OfficerS - Sale$9.53-1,68661,137-3%-$16,068-50+2
2017-02-15
NVTADumond PattyVP Fin., Principal Acct. OfficS - Sale$9.55-1,26454,665-2%-$12,068-50+2
2017-02-15
NVTABrida ThomasGCS - Sale$9.54-79425,486-3%-$7,573-50+2
2017-02-15
NVTABendekgey E LeeCFOS - Sale$9.59-2,09858,784-3%-$20,120-50+2
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top